Frost Radar：人工智慧驅動的藥物發現，2025 年

Frost Radar: AI-Enabled Drug Discovery, 2025

出版日期: 2025年12月12日 | 出版商:

Frost & Sullivan | 英文 62 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

鼓勵企業採取行動（C2A）的標竿管理體系－創新能加速新業務的創造與成長。

長期以來，由於大量生物數據的處理和解讀極為複雜，針對未滿足醫療需求的疾病發現新的藥物標靶一直面臨挑戰。臨床和研究數據的數量和可靠性不斷提高，使得雲端運算、人工智慧、機器學習、自然語言處理和進階分析等輔助工具和技術的應用變得至關重要。這促使藥物發現和開發從傳統的、緩慢的方法轉向相對快速、精簡且數據驅動的方法。為了保持競爭力，產業相關人員必須在數據、人工智慧和運算能力之間找到合適的平衡點，並將其與濕實驗室能力相協調。由於藥物發現主要涉及對生物網路和藥物-靶點相互作用的理解，因此人工智慧被無縫整合，以實現對特異性疾病未滿足治療靶點的識別和優先排序。供應商與產業的夥伴關係持續擴展，特別著重於發現用於治療腫瘤、神經系統疾病、老齡化和罕見疾病的新型化合物。許多成熟的公司已經擁有成功的臨床階段分子，這些分子或是透過與製藥公司合作開發和授權協議來獲得，或透過內部研發獲得。

Frost & Sullivan公司對產業內的眾多公司進行分析。公司根據其領導力及其他特徵進行篩選，然後根據十項成長和創新標準進行基準測試，以確定其在弗若斯特階梯上的位置。本出版品為每家公司提供一份弗若斯特階梯上的競爭概況，其中考慮了公司的優勢以及最能發揮這些優勢的機會。

The discovery of new drug targets for diseases with unmet medical needs has long been hindered by the complexity of processing and interpreting massive volumes of biological data. The increasing volume and veracity of clinical and research data compels the use of enabling tools and technologies, such as cloud computing, AI, machine learning, natural language processing, and advanced analytics, to make the shift from the slow, traditional approach to drug discovery and development to one that is relatively fast, rational, and data-driven. To remain competitive, industry players need to establish the right balance of data, AI, and computational capability and match it with the wet lab capability. With drug discovery being primarily about understanding biological networks and drug-target interactions, AI has been seamlessly integrating itself to allow identification and prioritization of disease-specific unmet therapeutic targets. Vendor/pharmaceutical industry partnerships continue to grow, with a focus on discovery of novel compounds for treatments related to oncology, neurological conditions, aging, and rare diseases. Most established companies have successful clinical-stage molecules either in co-development/licensing agreements with pharma or developed in-house.

Frost & Sullivan analyzes numerous companies in an industry. Those selected for further analysis based on their leadership or other distinctions are benchmarked across 10 Growth and Innovation criteria to reveal their position on the Frost Radar. The publication presents competitive profiles of each company on the Frost Radar considering their strengths and the opportunities that best fit those strengths.